Yahoo · Sep 18, 2026
Top Research Reports for AMD, Linde & Amgen
AMD, Linde and Amgen highlight AI demand, contracted growth and drug launches, while supply, margin and pipeline risks remain key factors.
VA
NYSE · VATE
INNOVATE Corp.
Industrials · Engineering & Construction
$7.30
Down-$0.13 (-1.78%)
Updated Oct 8, 2026, 3:26 PM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 59.22M
- P/E ratio
- -0.78
- Dividend yield
- 0.00%
- 52-week range
- $3.75 – $21.30
- Volume
- 54.96K
- Avg. volume
- 32.66K
Price performance · VATE
VATE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
VATE closed at $7.30 after 21 trading sessions, up 7.51% for the selected period.
- Last close
- $7.30
- Period change
- +7.51%
- Period low
- $6.79
- Period high
- $8.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $7.09 | $7.34 | $7.06 | $7.30 | 54.96K |
| Oct 6, 2026 | $7.32 | $7.40 | $7.035 | $7.19 | 57.55K |
| Oct 5, 2026 | $7.48 | $7.60 | $7.23 | $7.44 | 57.66K |
| Oct 2, 2026 | $7.50 | $7.66 | $7.11 | $7.50 | 40.24K |
| Oct 1, 2026 | $7.41 | $7.59 | $7.25 | $7.43 | 32.73K |
| Sep 30, 2026 | $7.68 | $7.68 | $7.0822 | $7.43 | 65.47K |
| Sep 29, 2026 | $7.35 | $7.55 | $7.32 | $7.55 | 37.37K |
| Sep 28, 2026 | $7.53 | $7.78 | $7.26 | $7.40 | 105.09K |
| Sep 25, 2026 | $7.47 | $7.855 | $7.41 | $7.77 | 83.59K |
| Sep 24, 2026 | $7.68 | $7.68 | $7.35 | $7.52 | 40.84K |
| Sep 23, 2026 | $8.05 | $8.1553 | $7.68 | $7.68 | 110.07K |
| Sep 22, 2026 | $8.13 | $8.1807 | $7.99 | $8.18 | 60.87K |
| Sep 21, 2026 | $8.01 | $8.20 | $7.44 | $8.18 | 156.95K |
| Sep 18, 2026 | $7.82 | $8.18 | $7.51 | $8.16 | 274.82K |
| Sep 17, 2026 | $7.64 | $8.25 | $7.56 | $7.86 | 222.18K |
| Sep 16, 2026 | $6.93 | $7.55 | $6.93 | $7.50 | 128.08K |
| Sep 15, 2026 | $7.29 | $7.2985 | $6.72 | $7.01 | 106.77K |
| Sep 14, 2026 | $7.06 | $7.34 | $7.00 | $7.24 | 57.68K |
| Sep 11, 2026 | $7.07 | $7.35 | $6.5441 | $7.16 | 99.28K |
| Sep 10, 2026 | $6.60 | $7.13 | $6.60 | $7.08 | 60.85K |
| Sep 9, 2026 | $7.07 | $7.105 | $6.65 | $6.79 | 105.79K |
Latest VATE news
The latest Smart Investors Daily articles mentioning VATE.
Stock researchCompany · Overview
Company
Market Activity
Research & News
VATE research
Overview
Company profile and research snapshot.
Company profile
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Aug 29, 2026
Could IES Holdings (IESC) Win Big While INNOVATE (VATE) Bets its Future on Debt Reduction?
On August 10, IES Holdings, Inc. (NASDAQ:IESC) announced a definitive agreement to acquire DBM Global from INNOVATE Corp. (NYSE:VATE) for approximately $650 million in combined cash and stock ($685 million total consideration including minority interest buyouts and tax election payments). This major structural deal reshapes both companies, but their underlying financial trajectories explain why the […]
SeekingAlpha · Aug 13, 2026
Innovate: This Is Not What I Expected At All, I Reiterate My Sell Rating
INNOVATE Corp (VATE) sells DBM Global, shifting to a biotech-style MediBeacon bet. Click here to read my most recent analysis of VATE stock.
Benzinga · Aug 10, 2026
INNOVATE Files $100M Mixed Securities Shelf Registration Statement
https://www.sec.gov/Archives/edgar/data/1006837/000100683726000080/a2026forms-3registrationst.htm
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
